| Nuclear receptor coactivators: master regulators of human health and disease S Dasgupta, DM Lonard, BW O'Malley Annual review of medicine 65, 279-292, 2014 | 218 | 2014 |
| Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer S Dasgupta, K Rajapakshe, B Zhu, BC Nikolai, P Yi, N Putluri, JM Choi, ... Nature 556 (7700), 249-254, 2018 | 187 | 2018 |
| Coactivator SRC-2–dependent metabolic reprogramming mediates prostate cancer survival and metastasis S Dasgupta, N Putluri, W Long, B Zhang, J Wang, AK Kaushik, JM Arnold, ... The Journal of clinical investigation 125 (3), 1174-1188, 2015 | 106 | 2015 |
| MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1 S Rajendiran, AV Parwani, RJ Hare, S Dasgupta, R Rhonda K, ... Molecular cancer 13 (1), 250, 2014 | 97 | 2014 |
| Oncogenic activation in prostate cancer progression and metastasis: Molecular insights and future challenges S Dasgupta, S Srinidhi, JK Vishwanatha Journal of carcinogenesis 11, 2012 | 93 | 2012 |
| Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer AK Kaushik, A Shojaie, K Panzitt, R Sonavane, H Venghatakrishnan, ... Nature communications 7 (1), 11612, 2016 | 82 | 2016 |
| TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis R Singh, D Karri, H Shen, J Shao, S Dasgupta, S Huang, DP Edwards, ... The Journal of Clinical Investigation 128 (7), 3129-3143, 2018 | 71 | 2018 |
| Coactivator-dependent oscillation of chromatin accessibility dictates circadian gene amplitude via REV-ERB loading B Zhu, LA Gates, E Stashi, S Dasgupta, N Gonzales, A Dean, CC Dacso, ... Molecular cell 60 (5), 769-783, 2015 | 71 | 2015 |
| SRC-2 is an essential coactivator for orchestrating metabolism and circadian rhythm E Stashi, RB Lanz, J Mao, G Michailidis, B Zhu, NM Kettner, N Putluri, ... Cell reports 6 (4), 633-645, 2014 | 71 | 2014 |
| Novel gene C17orf37 in 17q12 amplicon promotes migration and invasion of prostate cancer cells S Dasgupta, LM Wasson, N Rauniyar, L Prokai, J Borejdo, ... Oncogene 28 (32), 2860-2872, 2009 | 70 | 2009 |
| MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression M Kpetemey, S Dasgupta, S Rajendiran, S Das, LD Gibbs, P Shetty, ... Molecular cancer 14, 1-13, 2015 | 64 | 2015 |
| Transcriptional coregulators: emerging roles of SRC family of coactivators in disease pathology S Dasgupta, BW O'Malley Journal of molecular endocrinology 53 (2), R47-R59, 2014 | 54 | 2014 |
| Transcriptional repression of SIRT3 potentiates mitochondrial aconitase activation to drive aggressive prostate cancer to the bone A Sawant Dessai, MP Dominguez, UI Chen, J Hasper, C Prechtl, C Yu, ... Cancer research 81 (1), 50-63, 2021 | 47 | 2021 |
| HER2 signaling drives DNA anabolism and proliferation through SRC-3 phosphorylation and E2F1-regulated genes BC Nikolai, RB Lanz, B York, S Dasgupta, N Mitsiades, CJ Creighton, ... Cancer research 76 (6), 1463-1475, 2016 | 43 | 2016 |
| Signal transducer and activator of transcription 6 (STAT6) is a novel interactor of annexin A2 in prostate cancer cells S Das, P Shetty, M Valapala, S Dasgupta, Z Gryczynski, JK Vishwanatha Biochemistry 49 (10), 2216-2226, 2010 | 43 | 2010 |
| Prenylated c17orf37 induces filopodia formation to promote cell migration and metastasis S Dasgupta, I Cushman, M Kpetemey, PJ Casey, JK Vishwanatha Journal of Biological Chemistry 286 (29), 25935-25946, 2011 | 42 | 2011 |
| High MYC mRNA expression is more clinically relevant than MYC DNA amplification in triple-negative breast cancer E Katsuta, L Yan, T Takeshita, KA McDonald, S Dasgupta, M Opyrchal, ... International journal of molecular sciences 21 (1), 217, 2019 | 38 | 2019 |
| High expression of Annexin A2 is associated with DNA repair, metabolic alteration, and worse survival in pancreatic ductal adenocarcinoma H Takahashi, E Katsuta, L Yan, S Dasgupta, K Takabe Surgery 166 (2), 150-156, 2019 | 33 | 2019 |
| MIEN1 promotes oral cancer progression and implicates poor overall survival S Rajendiran, M Kpetemey, S Maji, LD Gibbs, S Dasgupta, R Mantsch, ... Cancer biology & therapy 16 (6), 876-885, 2015 | 32 | 2015 |
| Metabolic dysregulation controls endocrine therapy–resistant cancer recurrence and metastasis MA Blundon, S Dasgupta Endocrinology 160 (8), 1811-1820, 2019 | 15 | 2019 |
Bert W. O'MalleyBaylor College of MedicineVerified email at bcm.edu
